Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
NCT03297879
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
230
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes
Interventions
DRUG:
Exenatide or metformin hydrochloride
Sponsor
Beijing Chao Yang Hospital